Caffeine and the anticonvulsant potency of antiepileptic drugs: experimental and clinical data.

Journal Title: Pharmacological Reports - Year 2011, Vol 63, Issue 1

Abstract

Caffeine (1,3,7-trimethylxanthine) is the most commonly ingested stimulant in the world. The daily consumption of this methylxanthine in coffee, tea and soft drinks is approximately 200 mg per person, which yields a pharmacologically active blood concentration. Experimental data indicate that caffeine may either lower the convulsive threshold in experimental models of epilepsy or induce seizure activity in doses over 400 mg/kg in rodents. Interestingly, animal data have demonstrated that caffeine, at doses far below its convulsive potential, diminishes the protective effects of conventional antiepileptic drugs (AEDs--carbamazepine, phenobarbital, phenytoin, valproate) and the newer AED, topiramate against electroconvulsions in mice. However, in contrast to these AEDs, caffeine did not impair the anticonvulsant efficacy of other newer AEDs, lamotrigine, tiagabine, and oxcarbazepine in this experimental model of epileptic seizure. Although limited, the clinical data generally confirm the experimental findings, suggesting increased seizure frequency in epileptic patients who began ingesting caffeine in high quantities. Thus far, no analysis has been performed in epileptic patients to determine whether the hazardous effects of caffeine are dependent upon individual antiepileptic treatments. These data clearly indicate that methylxanthines should be avoided in epileptic patients.

Authors and Affiliations

Magdalena Chrościńska-Krawczyk, Małgorzata Jargiełło-Baszak, Bożydar Tylus, Stanisław Czuczwar

Keywords

Related Articles

Luminal melatonin stimulates pancreatic enzyme secretion via activation of serotonin-dependent nerves.

Background: Serotonin (5-HT) is released from enterochromaffin cells in the gastrointestinal tract. 5-HT, via the activation of 5-HT2 and 5-HT3 receptors on vagal fibers, mediates pancreatic secretion through the mechani...

Effect of repeated co-treatment with fluoxetine and amantadine on the behavioral reactivity of the central dopamine and serotonin system in rats.

In the present study we found that repeated co-treatment with fluoxetine and amantadine for 14 days (but not for 7 days) enhanced the hyperactivity induced by amphetamine or quinpirole (a dopamine D(2/3) agonist), compar...

Memory-related effects of cholinergic receptor ligands in mice as measured by the elevated plus maze test.

The purpose of our experiments was to examine the influence of cholinergic receptor ligands on memory-related behavior in mice using the elevated plus maze (EPM) test. The EPM test allows the exploration of different mem...

Central effect of crocin on penicillin-induced epileptiform activity in rats.

In the present study, the effects of separate and combined intracerebroventricular (icv) injections of crocin and diazepam were investigated on penicillin-induced epileptiform activity. In urethane-anesthetized rats, epi...

Influence of bupropion and calcium channel antagonists on the nicotine-induced memory-related response of mice in the elevated plus maze.

In this study, we investigated the effects of acute administration of nicotine on memory-related behavior in mice using the elevated plus maze test. In this test, the time necessary for mice to move from the open arm to...

Download PDF file
  • EP ID EP91933
  • DOI -
  • Views 93
  • Downloads 0

How To Cite

Magdalena Chrościńska-Krawczyk, Małgorzata Jargiełło-Baszak, Bożydar Tylus, Stanisław Czuczwar (2011). Caffeine and the anticonvulsant potency of antiepileptic drugs: experimental and clinical data.. Pharmacological Reports, 63(1), 12-18. https://europub.co.uk/articles/-A-91933